A new approach to antenatal screening for Fragile X syndrome

Prenatal Diagnosis

Volumn 23, Issue 4, 2003, Pages 345-351

  Wald, N J ^a   Morris, J K ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Fragile X syndrome; Screening; Sex determination

Indexed keywords

DNA;

AMNIOCENTESIS; ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; CHORION VILLUS SAMPLING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DOWN SYNDROME; FEMALE; FETUS; FETUS CELL; FRAGILE X SYNDROME; GESTATIONAL AGE; HUMAN; MAJOR CLINICAL STUDY; MALE; MATERNAL BLOOD; MATERNAL SERUM; NUCLEOTIDE REPEAT; POLYMERASE CHAIN REACTION; PRENATAL DIAGNOSIS; PRENATAL PERIOD; PRIORITY JOURNAL; SCREENING TEST; SEX DETERMINATION; SOUTHERN BLOTTING;

ADULT; DNA; FALSE POSITIVE REACTIONS; FEMALE; FRAGILE X SYNDROME; GENETIC SCREENING; GESTATIONAL AGE; HUMANS; MALE; MENTAL RETARDATION; PHENOTYPE; POLYMERASE CHAIN REACTION; PREGNANCY; PRENATAL DIAGNOSIS; SEX DETERMINATION (ANALYSIS); TRINUCLEOTIDE REPEAT EXPANSION;

EID: 0037395258     PISSN: 01973851     EISSN: None     Source Type: Journal    
DOI: 10.1002/pd.586     Document Type: Article

References (41)

1. Abrams MT, Reiss AL, Freund LS, et al. 1994. Molecular-neurobehavioral association in females with the Fragile X full mutation. Am J Med Genet 51: 317-327.
2. Ashley AE, Sherman SL. 1995. Population dynamics of a meiotic/mitotic expansion model for the Fragile X syndrome. Am J Hum Genet 57: 1414-1425.
3. Bennetto LMA, Pennington BF. 1996. The neuropsychology of Fragile X syndrome. In Fragile X Syndrome. Diagnosis, Treatment and Research, Hagerman RJ, Cronister A (eds). The Johns Hopkins University Press: Baltimore; 210-248.
4. Brown WT, Houck Jr G, Jeziorowska A, et al. 1993. Rapid Fragile X carrier screening and prenatal diagnosis by a non-radioactive PCR test. J Am Med Assoc 270: 1569-1575.
5. Brown WT. 1996. The molecular biology of the Fragile X mutation. In Fragile X Syndrome. Diagnosis, Treatment and Research, Hagerman RJ, Cronister A (eds). The Johns Hopkins University Press: Baltimore; 88-113.
6. Brown WT, Nolin S, Houck Jr G, et al. 1996. Prenatal diagnosis and carrier screening for Fragile X by PCR. Am J Med Genet 64: 191-195.
7. Costa J-M, Benachi A, Gautier E, et al. 2001. First-trimester fetal sex determination in maternal serum using real-time PCR. Prenat Diagn 21: 1070-1074.
8. Cronister A, Hagerman RJ, Wittenberger M, Amiri K. 1991. Mental impairment in cytogenetically positive Fragile X females. Am J Med Genet 38: 503-504.
9. Cuckle HS, Richardson GA, Sheldon TA, Quirke P. 1995. Cost effectiveness of antenatal screening for cystic fibrosis. BMJ 311: 1460-1464.
10. Dawson AJ, Chodirker BN, Chudley AE. 1995. Frequency of FMR1 premutations in a consecutive newborn population by PCR screening of Guthrie blood spots. Biochem Mol Med 56: 63-69.
11. de Vries BBA, Wiegers AM, Smits APT, et al. 1996. Mental status of females with an FMR1 gene full mutation. Am J Hum Genet 58: 1025-1032.
12. Elliott D, Jackson JM, Graves JP. 1981. The Oxfordshire mental handicap register. BMJ 282: 789-792.
13. Fisch GS, Snow K, Stephen N, et al. 1995. The Fragile X premutation in carriers and its effect on mutation size in offspring. Am J Hum Genet 56: 1147-1155.
14. Freund LS, Reiss AL. 1991. Cognitive profiles associated with the Fra(X) syndrome in males and females. Am J Med Genet 38: 542-547.
15. Fu YH, Kuhl DPA, Pizzuti A, et al. 1991. Variation of the CGG repeat at the Fragile X site results in genetic instability: resolution of the Sherman paradox. Cell 67: 1047-1058.
16. Geva E, Yaron Y, Shomrat R, et al. 2000. The risk of Fragile X premutation expansion is lower in carriers detected by general prenatal screening than in carriers from known Fragile X families. Genet Test 4: 289-292.
17. Hagerman RJ. 1996. Physical and behavioral phenotype. In Fragile X syndrome. Diagnosis, treatment and research, Hagerman RJ, Cronister A (eds). The Johns Hopkins University Press: Baltimore; 3-87.
18. Kremer EJ, Pritchard M, Lynch M, et al. 1991. Mapping of DNA instability at the Fragile X to a trinucleotide repeat sequence p(CGG)n. Science 252: 1711-1714.
19. Loesch DZ, Hay DA. 1988. Clinical features and reproductive patterns in Fragile X female heterozygotes. J Med Genet 25: 407-414.
20. Murray J, Cuckle H, Taylor G, Hawison J. 1997. Screening for Fragile X syndrome. Health Technol Assess 1(4): 46-47.
21. Office for National Statistics. 1995. 1995 Birth Statistics. Series FM1 No. 24. (England and Wales). xii.
22. Pesso R, Berkenstadt M, Cuckle H, et al. 2000. Screening for Fragile X Syndrome in women of reproductive age. Prenat Diagn 20: 611-614.
23. Reiss AL, Freund LS, Baumgardner TL, et al. 1995. Contribution of the FMR1 gene mutation to human intellectual dysfunction. Nat Genet 11: 331-334.
24. Rousseau F, Heitz D, Oberle I, Mandel JL. 1991a. Selection in blood cells from female carriers responsible for variable phenotypic expression of the Fragile X syndrome: inverse correlation between age and proportion of active X-carrying the full mutation. J Med Genet 28: 830-836.
25. Rousseau F, Heitz D, Biancalana V, et al. 1991b. Direct diagnosis by DNA analysis of the Fragile X syndrome of mental retardation. N Engl J Med 325: 1673-1681.
26. Rousseau F, Heitz D, Tarleton J, et al. 1994. A multicenter study on genotype-phenotype correlations in Fragile X syndrome, using direct diagnosis with probe StB128: the first 2253 cases. Am J Hum Genet 55: 225-237.
27. Rousseau F, Rouillard P, Morel ML, et al. 1995. Prevalence of carriers of premutation-size alleles of the FMRI gene-and implications for the population genetics of the Fragile X syndrome. Am J Hum Genet 57: 1006-1018.
28. Ryynanen M, Heinonen S, Makkonen M, Kajanoja E, Mannermaa A, Pertti K. 1999. Feasibility and acceptance of screening for Fragile X mutations in low-risk pregnancies. Eur J Human Genet 7: 212-216.
29. Screening brief. 1996. Screening brief: Cystic fibrosis. J Med Screen 3: 55-.
30. Sherman S. 1996. Epidemiology. In Fragile X Syndrome. Diagnosis, Treatment and Research. Hagerman RJ, Cronister A (eds). The Johns Hopkins University Press: Baltimore; 165-192.
31. Sherman SL, Meadows KL, Ashley AE. 1996. Examination of factors that influence the expansion of the Fragile X mutation in a sample of conceptuses from known carrier females. Am J Med Genet 64: 256-250.
32. Snow K, Doud LK, Hagerman R, et al. 1993. Analysis of a CGG sequence at the FMR-1 locus in Fragile X families and in the general population. Am J Hum Genet 53: 1217-1228.
33. Taylor AK, Safanda JF, Fall MZ, et al. 1994. Molecular predictors of cognitive involvement in female carriers of Fragile X syndrome. JAMA 271: 507-514.
34. Toledano-Alhadef H, Basel-Vanagaite L, Magal N, et al. 2001. Fragile-X carrier screening and the prevalence of pre-mutation and full-mutation carriers in Israel. Am J Hum Genet 69: 351-360.
35. Turner G, Webb T, Wake S, Robinson H. 1996. Prevalence of Fragile X syndrome. Am J Med Genet 64: 196-197.
36. Wald NJ. 1995. Biochemical detection of neural tube defects and Down's syndrome. In Turnbulls Obstetrics, Chamberlain G (ed.). Churchill Livingstone Press: Edinburgh 195-209.
37. Wald NJ, Densem JW, George L, et al. 1996. Prenatal screening for Down's syndrome using Inhibin-A as a serum marker. Prenat Diagn 16: 143-153.
38. Weinhausel A, Haas OA. 2001. Evaluation of the Fragile X (FRAXA) syndrome with methylation-sensitive PCR. Hum Genet 108: 450-458.
39. Willemsen R, Oosterwijk JC, Los FJ, Oostra BA. 1996. Prenatal diagnosis of Fragile X syndrome. Lancet 348: 967-968.
40. Willemsen R, Los F, Mohkamsing S, et al. 1997. Rapid antibody test for prenatal diagnosis of Fragile X syndrome on amniotic fluid cells: a new appraisal. J Med Genet 34: 250-251.
41. Yu S, Pritchard M, Kremer E, et al. 1991. Fragile X genotype characterized by an unstable region of DNA. Science 252: 1179-1181.